The Tell-Tale Heart: The Pharmacist's Cardiovascular Digest
The Tell-Tale Heart: The Pharmacist's Cardiovascular Digest
This podcast delivers concise clinical updates in cardiology alongside insightful career stories from pharmacists in the field. Host Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, CACP, provides essential knowledge and practical perspectives for pharmacy professionals specializing in cardiovascular care.
Author
The Tell-Tale Heart: The Pharmacist's Cardiovascular Digest
Category
Podcast website
Latest episode
Jun 24, 2026
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
34: Putting the 2026 CKM Guidelines Into Practice: A Pharmacist's Perspective 24.06.2026 33:41
In this episode of The Tell-Tale Heart, host Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP, welcomes back Lavinia Salama, PharmD, BCACP, BCGP, BC-ADM, CDCES, for an in-depth look at the new cardiovascular-kidney-metabolic (CKM) guidelines and how they translate into everyday practice. Salama says she's encouraged that CKM recommendations have evolved from a conceptual fra...
33: Craig Beavers, PharmD Breaks Down the 2026 CKM Guidelines — And Why They Matter 10.06.2026 12:09
In this solo episode of the Tell-Tale Heart podcast, host Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP, delivers an immediate reaction to the newly released 2026 AHA/ACC/ADA/ASN guidelines for cardiovascular kidney metabolic (CKM) syndrome. Beavers calls the document a landmark framework that formally unites obesity, diabetes, chronic kidney disease, heart failure, and a...
32: What's Making Headlines in Cardiovascular Care: A Pharmacist's Breakdown of the Latest Breakthroughs 27.05.2026 8:55
In this mini news episode of the Tell-Tale Heart podcast, host Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP, highlights three major developments in cardiovascular and cardiometabolic medicine that pharmacists should have on their radar.
31: From Misdiagnosis to Advocacy: Addressing Bias and Equity in Heart Failure Management 12.05.2026 53:56
In this episode of The Tell-Tale Heart, host Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP, speaks with Rhonda Monroe, MBA, a heart failure survivor and lead advocate at HeartLife, about her lived experience with spontaneous coronary artery dissection (SCAD) and the systemic failures that nearly cost her life. Following the birth of her third child, Monroe experienced cla...
30: Debriefing ACC 2026: Key Cardiovascular Trials and Their Clinical Implications for Pharmacists 28.04.2026 55:40
SPIRIT-HF CHAMPION-AF SMART-DECISION VESALIUS-CV (sub-study) CORAL REEF Ez-PAVE
29: New Dyslipidemia Guidelines Restore LDL Goals and Expand Pharmacist Opportunities 31.03.2026 48:00
You can learn more about the 2026 dyslipidemia guidelines here: 2026 Dyslipidemia Guideline Hub | JACC
27: Pharmacists’ Evolving Role in Electrophysiology Takes Center Stage Ahead of ACC 2026 17.03.2026 37:09
You can reach the guests on this episode here: Kristen Campbell, PharmD
28: Unpacking the 2025 ACC/AHA Pulmonary Embolism Guidelines With a Thrombosis Pharmacist 03.03.2026 49:50
Learn more about the HI-PEITHO trial here . You can reach the guest on this episode here: Allison Burnett, PharmD, PhC, CACP, on LinkedIn
27: Addressing Gaps in Secondary Stroke Prevention With Factor XIa Inhibition 17.02.2026 10:55
Learn more about the OCEANIC-STROKE trial here.
26: Pharmacist-Led Strategies Offer Solutions to Ongoing Hypertension Control Failures 10.02.2026 7:18
In this Heart Month solo episode of the Tell-Tale Heart podcast, host Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP, examines the “hypertension control paradox” outlined in a recent New England Journal of Medicine perspective, exploring why blood pressure control in the United States remains suboptimal despite effective therapies and long-standing clinical guidelines. Bea...
25: How the POLY-HF Trial Shows Pharmacists' Key Role in Heart Failure Care 03.02.2026 33:14
Learn more about the POLY-HF trial here . You can reach the guests on this episode here: Nick Miller, PharmD, on LinkedIn Nick Miller can be reached at nick@rxcompound.com Ambarish Pandey, MD, on LinkedIn
24: Hypertrophic Cardiomyopathy: What Pharmacists Need to Know in 2026 20.01.2026 51:11
Join us for a deep dive into hypertrophic cardiomyopathy (HCM) with Andrew Williford, PharmD, an assistant professor and cardiology specialist at UC San Diego Health. In this episode, we break down the genetics, diagnosis, and clinical impact of HCM, explore how management strategies have evolved, and discuss the emerging role of cardiac myosin inhibitors in treating obstructive disease. Dr. Willi...
23: Happy New Year from The Tell-Tale Heart! 06.01.2026 1:44
Happy New Year from The Tell-Tale Heart! We'll be back in 2 weeks with a new episode. In the meantime, check out the recent episode of Drugstore Dialogue with host Barry Newman, who spoke with Craig Beavers about cardiology pharmacy. Listen here: https://www.spreaker.com/episode/dr-craig-beavers--67706988
22: From Diagnosis to Transplant: A Heart Failure Patient’s Journey and the Pharmacists’ Impact Along the Way 16.12.2025 53:43
In this episode , host Craig Beavers sits down with Marc Baines, cofounder and executive director of the HeartLife Foundation, to explore heart failure care through the lens of lived experience. Diagnosed with heart failure at just 23 years old, Baines shares his path from sudden diagnosis to heart transplant and the critical role pharmacists played as consistent, trusted members of his care team....
21: Breaking Down Celebrate and POLY-HF: Two Paths to Better Cardiac Care 02.12.2025 12:54
In this solo episode, Craig Beavers breaks down new data from the CELEBRATE STEMI trial and the POLY-HF polypill study. He highlights what these findings could mean for real-world practice, from early antiplatelet strategies to improving adherence and outcomes in heart failure. Show Notes: Patient Perspectives on a Polypill Strategy for Heart Failure with Reduced Ejection Fraction: A Convergent-Pa...
20: Inside AHA’s Late-Breaking Lipid Trials: The Rise of Oral PCSK9 Inhibition 18.11.2025 1:02:48
This week, host Craig Beavers spoke with Joe Sassine, PharmD, BCPS, BCACP, CLS, about several key trials presented at the American Heart Association 2025 Scientific Sessions. Show notes: VESALIUS-CV trial: https://www.nejm.org/doi/full/10.1056/NEJMoa2514428 CORAL REEF trial
19: Jazzed Up for American Heart Association 2025 in New Orleans 04.11.2025 52:35
Studies discussed in today's episode: POLY-HF Trial CELEBRATE Trial VESALIUS-CV Trial
18: The Adipokine Hypothesis and Inflammation: Explaining Pathogenesis and Guiding Treatment 21.10.2025 30:01
The articles discussed in this episode: The Adipokine Hypothesis of Heart Failure With a Preserved Ejection Fraction: A Novel Framework to Explain Pathogenesis and Guide Treatment Inflammation and Cardiovascular Disease: 2025 ACC Scientific Statement: A Report of the American College of Cardiology
17: New Frontiers in Hypertension Care: Insights from the KARDIA-3 and Bax Hypertension Trials 07.10.2025 54:20
KARDIA-3 Study KARDIA 3 Study Design KARDIA 2 Study BaxHTN Study Shelby Tungate Lopez, PharmD, CPP, BCACP, MPA is a clinical pharmacist practitioner at the UNC Eshelman School of Pharmacy. He can be reached on Linkedin @ShelbyTungateLopez, and more information can be found about his interests and work at his faculty page .
16: Deconstructing Meta-Analyses From ESC 2025 23.09.2025 54:46
Pooled Analysis From VICTOR and VICTORIA Trials β Blocker After Myocardial Infarction Meta Analysis
15: ESC 2025 Highlights: Insights on ALONE-AF and AQUATIC Trials 09.09.2025 42:16
Host Craig Beavers sits down with Lorenz van der Linden, a Belgian pharmacist, to dive deep into 2 groundbreaking trials from the European Society of Cardiology (ESC) 2025 Congress. They explore the ALONE-AF trial, which examined anticoagulation strategies for patients with atrial fibrillation after catheter ablation, and the AQUATIC trial, which investigated the role of aspirin in patients on ora...
14: Sifting Through Discordant Data From ESC 2025 05.09.2025 50:17
Following the European Society of Cardiology Congress 2025, experts sat down again with host Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS (AQ-cards), CACP, to discuss key findings from the meeting. Kaitlin Hile, PharmD, BCCP; Robert Page, PharmD, MSPH, BCPS (AQ-cards), BCGP, FAHA, FHFSA, FCCP, FASHP; and Robert DiDomenico, PharmD, FCCP, FHFSA, FACC, reviewed new data from the meeting and pa...
13: From Guidelines to Action: Pharmacy’s Role in Hypertension Management 26.08.2025 40:40
In this episode, host Craig Beavers sits down with Gary Owen, clinical pharmacist and manager of Population Health Pharmacy Services at Vanderbilt University Medical Center, to discuss the newly updated ACC/AHA hypertension guidelines and what they mean for pharmacists. Gary shares how his team supports primary care providers across the state through collaborative practice agreements, innovative t...
12: A New Joint Scientific Statement and What to Watch for at the European Society of Cardiology Congress 2025 12.08.2025 27:04
This week, host Craig Beavers tackles the upcoming European Society of Cardiology (ESC) Congress 2025, taking place August 29 through September 1, 2025. Key data to keep an eye on will include the following: The VICTORION-Difference study of inclisiran in hyperlipidemia The Essence study of olezarsen in hypertriglyceridemia Multiple studies on early discontinuation of aspirin after percutaneous...
11: A Roundtable Discussion of Upcoming Hot Line Trials at ESC Congress 2025 29.07.2025 1:06:24
In this episode, Kaitlin Hile, PharmD, BCCP; Robert Page, PharmD, MSPH, BCPS (AQ-cards), BCGP, FAHA, FHFSA, FCCP, FASHP; and Robert DiDomenico, PharmD, FCCP, FHFSA, FACC, sat down with host Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS (AQ-cards), CACP, for an exciting discussion of several Hot Line trials at the upcoming European Society of Cardiology Congress 2025. Learn more about the ESC...
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.